Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Retained Earnings (2019 - 2025)

Biodesix (BDSX) has disclosed Retained Earnings for 7 consecutive years, with -$497.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 7.62% year-over-year to -$497.8 million, compared with a TTM value of -$497.8 million through Dec 2025, down 7.62%, and an annual FY2025 reading of -$497.8 million, down 7.62% over the prior year.
  • Retained Earnings was -$497.8 million for Q4 2025 at Biodesix, down from -$493.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$265.8 million in Q1 2021 and bottomed at -$497.8 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$392.9 million, with a median of -$405.0 million recorded in 2023.
  • The sharpest move saw Retained Earnings dropped 21.67% in 2022, then dropped 7.62% in 2025.
  • Year by year, Retained Earnings stood at -$302.0 million in 2021, then fell by 21.67% to -$367.4 million in 2022, then decreased by 14.19% to -$419.6 million in 2023, then dropped by 10.23% to -$462.5 million in 2024, then decreased by 7.62% to -$497.8 million in 2025.
  • Business Quant data shows Retained Earnings for BDSX at -$497.8 million in Q4 2025, -$493.8 million in Q3 2025, and -$485.1 million in Q2 2025.